There is an organ sitting behind my sternum that most of my patients have never heard of. Most of my colleagues rarely mention it. And yet, quietly, steadily, for the past four decades, it has been disappearing.

The thymus. The schoolhouse of the immune system. The place where T cells learn to distinguish self from non-self, friend from threat. By the time most of us reach our fifties, roughly 85 percent of it is gone, replaced by fat, retired from service, listed nowhere on the standard aging checklist we hand out at our patients’ annual physicals.

I am 65 years old. I am a physiatrist. And I have been thinking about aging, obsessively, clinically, personally, for most of my career.

This preoccupation didn’t begin recently. Years ago, I founded ForeverYoung.MD, an age-management clinic in Clearwater, Florida, built on a belief I held then and hold more firmly now: that aging is not simply something that happens to us, but something we can actively negotiate. I was not content to watch my patients accumulate years alongside disease. I wanted to show them (and myself) that the trajectory was not fixed.

That conviction eventually became books, lectures, a wellness program, and a daily personal practice that my colleagues sometimes find amusing and my patients occasionally find inspiring. I have written about epigenetics, weight loss, and the psychology of aging. I have argued, in clinical settings and in print, that lifestyle medicine is not soft medicine. It is the hardest medicine there is, because it demands something from the patient every single day.

And now, at 65, I find myself confronting an organ I did not think enough about when I was building all of that. The thymus. The science, when you sit with it, is both sobering and quietly remarkable. Thymic involution, the gradual atrophy of the gland across adulthood, is not a disease. It is a feature of normal aging, programmed and relentless. What it leaves behind is a narrowed T cell repertoire, a declining capacity to mount novel immune responses, and an immune system increasingly populated by memory cells that remember old battles but struggle with new ones.

This is, in large part, why older adults are disproportionately vulnerable to new infections, why vaccines work less robustly at 70 than at 30, and why cancer immunosurveillance falters with age. We tend to attribute these failures to aging in general. The thymus deserves more of the credit, or the blame.

What surprised me, as I went deeper into the literature, was how much the research community already knows about reversing this. Not halting it; reversing it. The TRIIM trial, combining growth hormone, DHEA, and metformin, produced a measurable reduction in epigenetic age, along with evidence of thymic regrowth on MRI. Animal studies have shown that restoring thymic epithelial cell function in aged mice improved T cell-mediated immunity and survival. Zinc supplementation, long dismissed as a wellness cliché, has genuine thymic data behind it. So does arginine, caloric restriction, and intermittent fasting.

Here is where it gets personal, and perhaps where some of my colleagues will raise an eyebrow. I am taking metformin. I am not diabetic. I take it because the evidence for its role in cellular aging, inflammation, and now thymic support is compelling enough that I am unwilling to wait for a consensus that may arrive a decade after I need it. I have optimized my vitamin D3. I track it, adjust it, and treat it with the same seriousness I would apply to any other modifiable biomarker in a patient I cared deeply about.

And I lift weights. Not the modest, careful weights of a 65-year-old being sensible. I lift more now than I did at 40. Deliberately, progressively, with the specific goal of stimulating endogenous growth hormone through resistance training, because growth hormone is one of the most studied signals for thymic regeneration, and the gym remains the most accessible way I know to raise it without a prescription.

I do these things not because I am certain they are working. I do them because the biology is plausible, the risks are manageable, and, if I am being fully honest, because I have never been wired to accept decline as a default setting.

Is what I am doing medicine? Or is it hope wearing a lab coat?

I have asked that question before, about regenerative injection therapy, about exercise prescriptions, about nutritional interventions that the mainstream dismissed before the data matured. The answers came slowly, imperfectly, but they came.

So I hold the thymus question the same way, with rigor where I can find it, and with the kind of open uncertainty that I think honest physicians owe themselves and their patients. We do not know yet what full thymic regeneration in a 65-year-old human looks like. We do not know which interventions will prove durable and which will become footnotes.

What I do know is that the organ behind my sternum is still there. Still functional, in its diminished way. Still, apparently, worth fighting for.

I have spent my career telling patients that change is possible, that the body, given the right inputs, is more responsive than we expect. It would be inconsistent of me, at 65, to stop believing that about my own.

Francisco M. Torres is an interventional physiatrist specializing in diagnosing and treating patients with spine-related pain syndromes. He is certified by the American Board of Physical Medicine and Rehabilitation and the American Board of Pain Medicine and can be reached at Florida Spine Institute and Wellness. 

Dr. Torres was born in Spain and grew up in Puerto Rico. He graduated from the University of Puerto Rico School of Medicine. Dr. Torres performed his physical medicine and rehabilitation residency at the Veterans Administration Hospital in San Juan before completing a musculoskeletal fellowship at Louisiana State University Medical Center in New Orleans. He served three years as a clinical instructor of medicine and assistant professor at LSU before joining Florida Spine Institute in Clearwater, Florida, where he is the medical director of the Wellness Program.

Dr. Torres is an interventional physiatrist specializing in diagnosing and treating patients with spine-related pain syndromes. He is certified by the American Board of Physical Medicine and Rehabilitation and the American Board of Pain Medicine. He is a prolific writer and primarily interested in preventative medicine. He works with all of his patients to promote overall wellness.